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Abstract Fatigue is often experienced after liver trans-
plantation. The aims of this cross-sectional study were to
assess physical Wtness (cardiorespiratory Wtness, neuromus-
cular Wtness, body composition) in liver transplant recipients
and to explore whether physical Wtness is related to severity
of fatigue. In addition, we explored the relationship between
physical Wtness and health-related quality of life. Included
were 18 patients 1–5 years after transplantation (aged
48.0 § 11.8 years) with varying severity of fatigue. Peak
oxygen uptake during cycle ergometry, 6-min walk distance,
isokinetic muscle strength of the knee extensors, body mass
index, waist circumference, skinfold thickness, severity of
fatigue, and health-related quality of life were measured.
Cardiorespiratory  Wtness in the liver transplant recipients
was on average 16–34% lower than normative values
(P · 0.05). Furthermore, the prevalence of obesity seemed
to be higher than in the general population (17 vs. 10%). We
found no deWcit in neuromuscular Wtness. Cardiorespiratory
Wtness was the only Wtness component that was related with
severity of fatigue (rs= ¡0.61 to rs= -0.50, P · 0.05). Par-
ticularly cardiorespiratory Wtness was related with several
aspects of health-related quality of life (rs= 0.48 to rs=0 . 7 0 ,
P · 0.05). Results of our study imply that cardiorespiratory
Wtness and body composition are impaired in liver transplant
recipients and that Wtness is related with severity of fatigue
(only cardiorespiratory Wtness) and quality of life (particu-
larly cardiorespiratory Wtness) in this group. These Wndings
have implications for the development of rehabilitation pro-
grams for liver transplant recipients.
Keywords Liver transplantation · Fatigue · Peak oxygen 
uptake · Isokinetic muscle strength · Body composition
Introduction
Liver transplantation (LTx) is the only deWnitive treatment
for end-stage liver disease. Since 1988, patient survival and
liver function after LTx have improved markedly, due to
improved technical expertise, better selection of patients,
improved post-LTx management of complications, and
improved immunosuppressive therapy (Adam et al. 2003).
In Europe, LTx has achieved a 1-year survival rate of 82%
(Burroughs et al. 2006).
Although studies have reported that quality of life
improves after LTx (Gross et al. 1999; van der Plas et al.
2003), limitations in daily function still remain (Gross et al.
1999; van der Plas et al. 2003). Amongst these limitations,
liver transplant recipients often experience fatigue (Aadahl
et al. 2002; Belle et al. 1997; Leyendecker et al. 1993; van
den Berg-Emons et al. 2006). Gross et al. (1999), and Belle
et al. (1997) reported that, although the intensity of fatigue
was reduced after LTx, fatigue remained the most distressing
symptom 1 year after surgery. Leyendecker et al. (1993)
found that 9 months after LTx, complaints of fatigue were
more severe in the LTx group than in the general population.
In a previous study, we found severe fatigue in 44% of
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patients up to 15 years after LTx, and these complaints did
not decrease over time (van den Berg-Emons et al. 2006a).
Rehabilitation programs might be eVective in reducing
severity of fatigue after LTx, but, to develop appropriate
programs, knowledge on the factors associated with fatigue
after LTx is necessary. However, data on these factors are
scarce. Aadahl et al. (2002) and van den Berg-Emons et al.
(2006a) suggested that the fatigue experienced by liver
transplant recipients is primarily physical, rather than psy-
chological. Furthermore, van den Berg-Emons et al.
(2006b) found that severe complaints of fatigue in liver
transplant recipients are associated with low levels of
everyday physical activity. A hypoactive lifestyle may lead
to a negative spiral: hypoactivity leading to a reduction in
physical Wtness and deterioration of complaints of fatigue,
leading to further hypoactivity.
Few studies have investigated the physical Wtness of
liver transplant recipients, but the limited data available
suggest a reduced physical Wtness after LTx (Beyer et al.
1999; Stephenson et al. 2001; Unnithan et al. 2001). Ste-
phenson et al. (2001) found a 40–60% lower maximal oxy-
gen uptake than predicted in liver transplant recipients.
Beyer et al. (1999) reported that, although the cardiovascu-
lar and neuromuscular Wtness in liver transplant recipients
improved after a supervised exercise program during the
post-operative year, maximal oxygen uptake and muscle
strength remained 10–20% lower compared to healthy gen-
der and age-matched individuals. Also in pediatric liver
transplant recipients, deWcits in cardiovascular Wtness, and
abdominal muscle strength have been reported (Unnithan
et al. 2001).
It may be hypothesized that deWcits in physical Wtness in
liver transplant recipients are associated with complaints of
fatigue. Furthermore, deWcits in physical Wtness may lead to
impaired health-related quality of life (HRQoL). However, to
our knowledge, no studies are available on the relationships
between these parameters in liver transplant recipients.
Because of the scarcity of studies on physical Wtness and
related parameters in liver transplant recipients, the present
study assessed physical Wtness (cardiorespiratory Wtness,
neuromuscular Wtness, and body composition) in liver trans-
plant recipients and explored whether physical Wtness is
related to severity of fatigue in this group. The relationship
between physical Wtness and HRQoL was also explored.
Patients and methods
Patients
To obtain a representative sample of liver transplant recipi-
ents with respect to fatigue, we recruited liver transplant
recipients with varying severity of fatigue, according to the
distribution of severity of fatigue as found in our previous
study in 96 liver transplant recipients (van den Berg-Emons
et al.  2006a). Severity of fatigue in this previous study
ranged from ‘no signs of fatigue’ to ‘most disabling
fatigue’, and was assessed with the Fatigue Severity Scale
of Krupp et al. (1989) (see below). Inclusion criteria for the
present study were: LTx between 1 and 5 years ago, suY-
cient knowledge of the Dutch language, and age between
18 and 65 years. Exclusion criteria were: multiorgan trans-
plant recipients, severe comorbidity, and contra-indication
for a progressive maximal cycle ergometer test. Of the orig-
inal sample of 96 patients in the previous study (van den
Berg-Emons et al. 2006a), 4 patients had died, 1 patient had
emigrated, 53 patients were transplanted more than 5 years
previously, and 10 patients were not eligible because of
contra-indications for a maximal cycle ergometer test. Of
the 28 eligible patients, 18 patients (64%) agreed to partici-
pate. There were no signiWcant diVerences in relevant char-
acteristics between the patients who decided to participate
and the non-participants. The study was approved by the
Medical Ethics Committee of the Erasmus University Med-
ical Center. Written informed consent was obtained from
all subjects. Table 1 shows the characteristics of the study
group.
Measurements
Physical Wtness: cardiorespiratory
Cardiorespiratory Wtness was measured with a progressive
maximal aerobic test on a cycle ergometer (ER800, Jaeger
Toennies, Breda, The Netherlands). The test was preceded
Table 1 Characteristics of the study group (n =1 8 )
Results are presented as mean § SD or numbers
a Chronic primary disease: cholestatic (n = 6), viral (n =6 ) ,  m i s c e l l a -
neous (n = 5); acute primary disease: intoxication (n =1 )
b Immunosuppressive agents: 1 agent, cyclosporine or tacrolimus; 2
agents, prednisone with tacrolimus; 3 agents, prednisone with tacroli-
mus and azathioprine
Age (years) 48.0 § 11.8
Gender
Male 11
Female 7
Primary disease (n) a
Chronic 17
Acute 1
Time since transplantation (years) 3.3 § 1.1
Immunosuppressive agentsb 
11 6
21
31Eur J Appl Physiol (2007) 100:345–353 347
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by a 1-min warm-up period (20 W). The test started at
20 W, and resistance was increased every minute by 15 or
20 W, depending on the ability of the patients. Individual
protocols were constructed such that the total exercise time
ranged from 8 to 12 min. The pedal rate was 60 rpm and
strong verbal encouragement was given during the test. The
test was terminated when the subject voluntarily stopped
due to exhaustion, or when the patient was unable to main-
tain the initial pedal rate. Gas exchange and heart rate (HR)
were measured continuously using a breath-by-breath gas
analysis system (K4b2, COSMED, Rome, Italy). Subjective
strain was measured immediately after the Wnal stage by the
Borg Category Scale for Rating of Perceived Exertion
(Borg 1982). Patients were asked to indicate how strenuous
they had experienced the test by giving a number from 0
(no eVort at all) to 10 (maximal eVort). Cardiorespiratory
Wtness was deWned as the mean oxygen uptake during the
last 30 s of exercise [VO2peak, in ml kg¡1 min¡1 and in
ml kg fat-free mass¡1 min¡1 (ml kgFFM
¡1 min¡1)]. In addi-
tion, the ventilatory anaerobic threshold (VAT, expressed
as percentage of predicted VO2peak) was estimated by the
ventilatory equivalent method, when VE/VO2 and PetO2
increased while VE/VCO2 and PetCO2 remained stable
(Reinhard et al. 1979; Wasserman et al. 1999).
Finally, patients performed the submaximal 6-min walk
test (6MWT) (Guyatt et al. 1985). Patients were instructed
to walk, not run, as far as they could along a 30-m marked
tape in a hall during a 6-min period. Standardized encour-
agement was provided with the following phrases: “You
are doing well” and “Keep up the good work”. Patients
were allowed to stop and rest during the test, but were
instructed to resume walking as soon as they felt able to do
so. The 6-min walk distance (6MWD) was registered.
Physical Wtness: neuromuscular
Isokinetic muscle strength of the knee extensors was
assessed in both legs by a Biodex® dynamometer (Shirley,
New York, USA), recording strength as torque in Nm. The
patients were seated against a back-rest, Wrmly strapped at
the hip and thigh. The rotational axis was aligned with the
lateral femoral epicondyle. After Wve familiarization repeti-
tions, isokinetic strength was measured at 60°/s with 5
maximal contractions and at 180°/s with 15 maximal con-
tractions. Strong verbal encouragement was given during
the test. Peak torque (PT) was deWned as the maximum
torque generated by the patients throughout one series of
repetitions at each velocity.
Physical Wtness: body composition
Height and body mass were measured without shoes. Body
mass was measured using a Cormier Paribel® weighing
chair (FH Balances Cormier, Romainville, France). Body
mass index (BMI, kg m¡2) was calculated from height and
body mass. Waist circumference (cm) was measured mid-
way between the lowest rib and the iliac crest while stand-
ing. Thickness of four skinfolds (biceps, triceps, subscapu-
lar, suprailiaca region) was measured twice at the right side
of the body with a Harpenden Skin-Fold Caliper (Burgess
Hill, UK). The mean of the two measurements was used as
representative for each site. Percentage body fat (BF) was
predicted from skinfold thickness according to the method
of Durnin and Womersley (1974).
Severity of fatigue
Severity of fatigue was assessed by the Dutch version of the
Fatigue Severity Scale (FSS) (Krupp et al. 1989). The FSS
is a self-administered questionnaire with answers ranging
from 1 (‘strongly disagree’) to 7 (‘strongly agree’). The
mean score of the nine inquiries ranges from 1 (‘no signs of
fatigue’) to 7 (‘most disabling fatigue’). Internal consis-
tency, reliability, validity, and sensitivity of the FSS have
been established in several patient groups (Krupp et al.
1989; Merkies et al. 1999).
In addition to the FSS, severity of fatigue was assessed
with a horizontal visual analogue scale (VAS). Patients
were asked to mark the 100-mm line according to how
intense they had experienced fatigue during the last month
(0 denotes ‘no fatigue experienced’ and 100 denotes ‘the
most severe fatigue’) (ter Borg et al. 2004). Visual ana-
logue scales have been found to yield reliable and valid
data (Huskisson 1982; Scott and Huskisson 1979).
Health-related quality of life
HRQoL was assessed by the validated Dutch version
(RAND-36) (van der Zee and Sanderman 1993) of the
Medical Outcomes Study Short Form-36 (SF-36) (Ware
and Sherbourne 1992). The SF-36 is a validated, self-
administered questionnaire used internationally to measure
health status with respect to diVerent dimensions: physical
functioning, social functioning, role limitations due to
physical problems, role limitations due to emotional prob-
lems, pain, mental health, vitality, general health percep-
tion, and change in perceived health during the last
12 months. All raw scores were converted to a 0–100 scale,
with higher scores indicating higher levels of functioning or
well-being.
Procedure
On the day of the measurements, patients refrained from
caVeine, nicotine, and heavy exercise. The order of the tests
was standardized: patients started with the 6MWT,348 Eur J Appl Physiol (2007) 100:345–353
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followed by the questionnaires (completed under supervi-
sion of the researcher), body composition measurements,
strength test, and Wnally the progressive maximal aerobic
test. Exercise tests were performed under supervision of a
physician. There were suYcient rest periods between the
tests.
Statistics
Statistical analysis was performed using SPSS 10.1 for
Windows (SPSS Inc., Chicago, IL, USA). Results are pre-
sented as mean § standard deviation (SD), range or num-
bers. Results on cardiorespiratory Wtness were compared to
normative values for sedentary persons and to normative
values for people who exercise no more than 1–2 h a week
(recreational) (Vos et al. 2001). Results on neuromuscular
Wtness were compared with the normative values of Akima
et al. (2001) and 6MWD was compared with the normative
values of Enright and Sherill in healthy adults aged 40–
80 years (1998). When patients were younger than
40 years, the normative values of Gibbons et al. (2001)
were used. Obesity was deWned as a BMI ¸ 30 (World
Health Organization 1989), a waist circumference ¸102 cm
in men and ¸88 cm in women (Lean et al. 1995) or per-
centage BF ¸25% in men and ¸32% in women (Lohman
1992).
DiVerences in physical Wtness between patients and nor-
mative values were tested with the non-parametric Mann-
Whitney U Test. Relationships between physical Wtness and
severity of fatigue and between physical Wtness and quality
of life were explored using the non-parametric Spearman
correlation coeYcient (rs). A probability value ·0.05 deter-
mined statistical signiWcance. However, because of the rel-
atively small study sample, also results on the  =0 . 1 0
level are presented (indicating a trend).
Results
Physical Wtness
Mean score on the Borg Scale was 6.3 § 2.2, indicating
that the patients experienced the maximal ergometer test on
average as heavy to very heavy. The mean HRmax was
90 § 10% of what was predicted (predicted HRmax= 220-
age) (Fox et al. 1971).
The individual results of the patients are presented in
Table 2. Table 3 shows the cardiorespiratory Wtness and
Table 2 Individual results on physical Wtness in the 18 liver transplant recipients
Abbreviations: BMI(kg m¡2), body mass index; Waist (cm), waist circumference; VO2peak(ml kg¡1 min¡1), peak oxygen uptake per kg; VO2peak
(ml kgFFM
¡1 min¡1), peak oxygen uptake per kg fat-free mass; VAT (% predicted VO2peak), ventilatory anaerobic threshold as percentage of pre-
dicted VO2peak; sed, sedentary normative values; recr, recreational normative values; 6MWD, 6-min walk distance; PT, peak torque
a Waist circumference: n = 14, because of thickness of the skin at the place of the cicatrice in four patients
b Body fat and VO2peak: n = 17, because the thickness of the subscapular skinfold could not be measured reliably in one patient
Age (year/
Gender)
BMI
(kg m¡2)
Waist
(cm)a
Body
fat (%)b
VO2peak
(ml kg¡1
min¡1)
VO2peak
(ml kgFFM
¡1
min¡1)b
VAT (% 
predicted
VO2peak sed) 
VAT (% 
predicted
VO2peak recr)
6MWD 
(m)
PT extension
60°/s (Nm)
PT extension
180°/s (Nm)
56/M 28.3 111.0 29.0 36.5 51.4 54.1 42.7 652 156.3 88.2
52/M 29.0 32.7 16.7 24.8 49.1 38.9 428 101.8 73.1
42/F 22.8 28.9 34.5 48.5 90.5 65.8 530 100.0 65.6
60/F 38.4 118.5 42.0 13.1 22.5 43.6 32.5 495 101.9 78.6
64/M 29.7 103.5 30.6 21.7 31.3 77.4 55.4 430 99.9 62.6
24/F 21.0 72.0 25.9 29.9 40.4 38.8 31.1 660 159.9 111.5
46/M 26.5 100.0 25.8 28.2 38.0 48.6 38.7 606 151.6 88.5
63/M 24.4 20.5 20.9 26.4 69.4 49.7 410 74.4 44.8
42/M 34.9 132.0 22.8 30.9 25.8 513 145.9 118.3
53/F 23.9 77.5 30.1 23.1 33.0 108.6 64.8 465 40.0 35.7
53/M 25.9 99.6 23.6 20.7 27.1 56.7 42.6 510 149.3 96.8
39/M 23.7 87.0 17.4 31.2 37.8 51.5 43.5 547 169.0 111.8
33/M 24.0 88.0 19.8 35.1 43.7 67.9 59.9 510 155.9 116.9
63/F 33.0 103.0 34.8 15.8 24.2 57.9 43.2 303 67.2 39.4
45/F 26.8 30.8 23.6 34.1 61.0 46.2 514 120.1 61.7
39/F 18.7 75.0 22.7 30.2 38.1 56.2 46.8 600 115.9 67.9
32/M 22.9 91.0 20.4 25.0 31.4 43.4 38.3 576 180.4 124.6
58/M 25.1 99.0 25.0 18.5 24.6 48.6 37.9 495 128.6 91.9Eur J Appl Physiol (2007) 100:345–353 349
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neuromuscular Wtness of the patients compared with nor-
mative values. VO2peak in ml kg¡1 min¡1  was 15 § 22%
(P = 0.07) and 34 § 15% (P = 0.00) lower than normative
values for, respectively, sedentary persons and those who
exercise recreationally. VO2peak in ml kgFFM
¡1 min¡1  was
16 § 19.2% (P = 0.02) and 33 § 14.8% (P =0 . 0 0 )  l o w e r
than normative values for, respectively, sedentary persons
and those who exercise recreationally. 6MWD was
16 § 14% (P = 0.01) lower than normative values. There
was no signiWcant deWcit in neuromuscular Wtness. Table 4
shows the body composition of the LTx group. According
to the cut-oV points for obesity based on BMI, waist cir-
cumference and percentage BF, respectively 17, 36, and
41% of the patients were classiWed as obese.
Relationships
Table 5 shows the correlation coeYcients between the
physical  Wtness parameters and severity of fatigue as
assessed with the FSS and VAS. None of the parameters of
neuromuscular  Wtness or body composition were signiW-
cantly related with severity of fatigue, assessed with either
the FSS or the VAS.
VO2peak in ml kgFFM
¡1 min¡1 (absolute and expressed as
percentage of recreational normative values) and 6MWD
(absolute) were related with severity of fatigue as assessed
Table 3 Cardiorespiratory Wtness and neuromuscular Wtness in the liver
transplant group
Results are presented as mean § SD
Abbreviations:  VO2peak(ml kg¡1 min¡1), peak oxygen uptake per kg;
VO2peak (ml kgFFM
¡1 min¡1), peak oxygen uptake per kg fat-free mass;
VAT (% predicted VO2peak), ventilatory anaerobic threshold as percentage
of predicted VO2peak; sed, sedentary normative values; recr, recreational
normative values (people who exercise no more than 1–2 h a week); 6MWD
6-min walk distance; PT, peak torque
a Vos et al. (2001), Enright and Sherill (1998), Gibbons et al. (2001), Ak-
ima et al. (2001)
b n = 17, because the thickness of the subscapular skinfold could not be
measured reliably in one patient
*S i g n i Wcant (P · 0.05) diVerence between patients and normative values
9 DiVerence between patients and normative values at the  = 0.10 level
(trend)
LTx group Norm valuesa P
Cardiorespiratory Wtness
VO2peak (ml kg¡1 min¡1)2 4 . 8 § 6.9 29.4 § 7.4 (sed) 0.079
37.5 § 6.7 (recr) 0.00*
VO2peak (ml kgFFM
¡1 min¡1)b 34.0 § 8.7 41.0 § 7.8 (sed) 0.02*
50.9 § 5.9 (recr) 0.00*
6MWD (m) 513.6 § 88.9 609.6 § 97.6 0.01*
Neuromuscular Wtness
PT extension at 60°/s (Nm) 123.2 § 38.7 138.5 § 44.1 0.22
PT extension at 180°/s (Nm)  82.1 § 27.9 86.1 § 30.1 0.59
Table 4 Body composition in the liver transplant group
Results are presented as mean § SD
a Waist circumference: n = 14, because of thickness of the skin at the
place of the cicatrice in four patients
b Body fat: n = 17, because the thickness of the subscapular skinfold
could not be measured reliably in one patient
Body composition Mean § SD
Body weight (kg) 80.6 § 18.3
Height (m) 1.74 § .11
Body mass index (kg m¡2) 26.6 § 5.0
Waist circumference (cm)a 96.6 § 16.8
Body fat (%)b 26.9 § 6.4
Table 5 Spearman correlation coeYcients for the relationships be-
tween Wtness parameters and severity of fatigue as measured with the
Fatigue Severity Scale (FSS) and the Visual Analogue Scale (VAS) in
18 liver transplant recipients
Abbreviations: VO2peak (ml kg¡1 min¡1), peak oxygen uptake per
kg; VO2peak (ml kgFFM
¡1 min¡1), peak oxygen uptake per kg fat-free
mass; VAT (% predicted VO2peak), ventilatory anaerobic threshold as
percentage of predicted VO2peak; sed, sedentary normative values; re-
cr, recreational normative values (people who exercise no more than 1–
2 h a week); 6MWD, 6-min walk distance; PT, peak torque
a n = 17, because the thickness of the subscapular skinfold could not
be measured reliably in one patient
b n = 14, because of thickness of the skin at the place of the cicatrice
in four patients
*S i g n i Wcant (P · 0.05) correlation
9 Correlation at the  = 0.10 level (trend)
Physical Wtness Fatigue
FSS VAS
Rs P Rs P
Cardiorespiratory Wtness
VO2peak (ml kg¡1 min¡1) ¡0.40 0.10 ¡0.52 0.03*
% of sedentary norm ¡0.17 0.50 ¡0.42. 0.089
% of recreational norm ¡0.32 0.20 ¡0.53 0.03*
VO2peak (ml kgFFM
¡1 min¡1)a ¡0.43 0.089 ¡0.51 0.04*
% of sedentary norma ¡0.35 0.17 ¡0.50 0.04*
% of recreational norma ¡0.45 0.079 ¡0.61 0.01*
VAT (% predicted VO2peak sed) 0.22 0.38 0.03 0.92
VAT (% predicted VO2peak recr) 0.17 0.49 ¡0.06 0.82
6MWD (m) ¡0.44 0.079 ¡0.53 0.03*
% of norm ¡0.25 0.32 ¡0.52 0.03*
Neuromuscular Wtness
PT extension at 60°/s (Nm) ¡0.39 0.11 ¡0.31 0.22
% of norm ¡0.15 0.56 ¡0.28 0.27
PT extension at 180°/s (Nm) ¡0.30 0.22 ¡0.12 0.64
% of norm 0.02 0.93 0.04 0.87
Body composition
Body mass index (kg m¡2) 0.03 0.91 0.06 0.82
Waist circumference (cm)b ¡0.07 0.82 ¡0.06 0.83
Body fat (%)a 0.32 0.21 0.15 0.58350 Eur J Appl Physiol (2007) 100:345–353
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with the FSS at the  = 0.10 level (trend). With respect to
the VAS, VO2peak in ml kg¡1 min¡1 (absolute and expressed
as percentage of recreational normative values), VO2peak in
ml kgFFM
¡1 min¡1 (absolute and expressed as percentage of
both sedentary and recreational normative values) and
6MWD (absolute and expressed as percentage of normative
values) were signiWcantly (P · 0.05) correlated with sever-
ity of fatigue. VO2peak in ml kg¡1min¡1 as percentage of
sedentary normative values was related with severity of
fatigue as assessed with the VAS at the  =0 . 1 0  l e v e l
(trend). The VAT was not correlated with severity of
fatigue, assessed with the FSS or the VAS.
Table 6 shows the correlation coeYcients between phys-
ical Wtness parameters and HRQoL. There were several sig-
niWcant correlations between physical Wtness and HRQoL
and particularly between cardiorespiratory Wtness on the
one hand and ‘Physical functioning’, ‘Social functioning’
and ‘Vitality’ on the other hand.
Discussion
This is the Wrst study in which relationships between sev-
eral aspects of physical Wtness and severity of fatigue are
explored after LTx. The study is an initial step in identify-
ing factors that are associated with fatigue in liver trans-
plant recipients. A limitation of this study may be that the
sample was relatively small. However, we believe that
this sample is representative for patients after LTx and
that the study provides important information for the
development of rehabilitation programs for liver trans-
plant recipients.
Physical Wtness
We found average deWcits in VO2peak of 16–34%, when we
compared the results in the liver transplant recipients with
normative values for, respectively, sedentary persons and
those who exercise no more than 1–2 h a week. We believe
that a value in between the sedentary and recreational nor-
mative values is representative for healthy Dutch persons of
the same age as the liver transplant recipients that partici-
pated in our study. 6MWD was 16% lower than normative
values. This subnormal level of cardiorespiratory Wtness
(both VO2peak and 6MWD) is in agreement with Wndings of
previous studies (Beyer et al. 1999; Stephenson et al. 2001;
Unnithan et al. 2001). Furthermore, the prevalence of obes-
ity was higher in this study than in the general Dutch popu-
lation; 17% of the patients had a BMI of more than 30
compared to 10% in the general Dutch population
(Gezondheidsraad 2003).
Impaired cardiorespiratory Wtness in liver transplant
recipients may be due to the use of immunosuppressive
medication, e.g. glucocorticoids and calcineurin inhibitors,
which may inXuence both the cardiovascular system and
skeletal muscles (Hokanson et al. 1995; Mercier et al.
1996). Immunosuppressive medication can also induce
appetite stimulation and diabetes mellitus; this in associa-
tion with emotional conditions can cause a change in eating
habits (Correia et al. 2003; Hussaini et al. 1998). Further-
more, patients with primary biliary cirrhosis and some
patients with other chronic liver disease are hypermeta-
bolic. LTx in these patients may lead to a reduction in rest-
ing metabolic rate and can also cause an increase in BF
(Hussaini et al. 1998; Richardson et al. 2001). Besides
immunosuppressive medication and changes in appetite
and metabolism, also deconditioning (both before and after
transplantation) may contribute to the impaired cardiorespi-
ratory Wtness and body composition (Epstein et al. 1998;
Grose et al. 1995). In a previous study we found that severe
complaints of fatigue were associated with low levels of
everyday physical activity in liver transplant recipients (van
den Berg-Emons et al. 2006b).
Because of the immunosuppressive medication and
deconditioning, we also expected a deWcit in neuromuscular
Wtness. However, this was not demonstrated in the present
study, in contrast to Beyer et al. (1999), who found a 10–
20% lower muscle strength in liver transplant recipients
compared to age- and sex-matched sedentary individuals.
They contributed this deWcit to muscle weakness as a side-
eVect of glucocorticoids.
The discrepancy between the Wndings of our study and
those of Beyer et al. (1999) may be explained by the use of
Tacrolimus instead of cyclosporine in the majority of our
subjects. Tacrolimus is known to have less side eVects than
cyclosporine (Maes and Vanrenterghem 2004).
Stephenson et al. (2001) reported an early VAT in liver
transplant recipients (<45–50% of the predicted VO2max)
compared to 50–60% of the VO2max in healthy persons
found by Davis et al. (1997). They contributed this early
anaerobic threshold in liver transplant recipients to the
cyclosporine-induced decrease in mitochondrial oxygen
consumption (2001). However, the European Respiratory
Society (ERS Task Force 1997) reported that there is a
wide range of normal predicted values (35–70%). There-
fore, it is diYcult to indicate whether the VAT in our
patients was reduced compared to normal (58.6 § 18.9 and
44.7 § 11.1% of predicted VO2peak for, respectively, seden-
tary persons and those who exercise recreationally).
Physical Wtness and severity of fatigue
Although relationships between severity of fatigue (as mea-
sured with the FSS and VAS) and physical Wtness were not
univocal, this study demonstrates a relationship between
cardiorespiratory Wtness and severity of fatigue after LTx.Eur J Appl Physiol (2007) 100:345–353 351
123
Patients with more severe complaints of fatigue had larger
deWcits in cardiorespiratory Wtness than patients with less
severe complaints of fatigue. Although this cross-sec-
tional study does not allow us to conclude that a reduced
cardiorespiratory Wtness results in fatigue (or vice versa),
there may be an interaction between parameters: com-
plaints of fatigue leading to decreased physical activity
(van den Berg-Emons et al. 2006b) and decreased physi-
cal Wtness, leading to further deterioration of complaints
of fatigue. It may then be hypothesized that rehabilitation
programs, aimed at enhancing cardiorespiratory Wtness,
can be eVective in breaking through this negative spiral
and (partly) reduce complaints of fatigue in this popula-
tion. However, this hypothesis has to be conWrmed in
future randomized trials.
In contrast to our expectations, the present study indi-
cates that other aspects of physical Wtness, neuromuscular
Wtness and body composition, do not seem to be related
with severity of fatigue after LTx. However, it should be
realized that our study sample was relatively small and
some of the studied relationships may have failed to show
statistical signiWcance.
Physical Wtness and HRQoL
Previous studies on healthy persons indicate that physical
activity,  Wtness, and body fatness are associated with
HRQoL and mood (Han et al. 1998; Stewart et al. 2003).
There are also indications that physical activity is related to
HRQoL after LTx (Painter et al. 2001; van den Berg-
Emons et al. 2006b). Therefore, we expected to Wnd a rela-
tionship between physical Wtness and HRQoL in our study
group. In agreement with the study of Stewart et al. (2003)
in healthy elderly subjects, we found several signiWcant
correlations between physical Wtness (particularly cardiore-
spiratory Wtness) and HRQoL in our liver transplant recipi-
ents. Patients with large deWcits in physical Wtness
experienced worse HRQoL than patients with small deWcits
in physical Wtness. However, in contrast with studies in
healthy persons (Han et al. 1998; Stewart et al. 2003), we
Table 6 Spearman correlations coeYcients for the relationships between physical Wtness and health-related quality of life as assessed with the
RAND¡36 in 18 liver transplant recipients
To enhance the clarity of the table, only signiWcant correlation coeYcients (P · 0.05, bold) or trends (P < 0.10, not bold) are presented
Abbreviations: VO2peak (ml kg¡1 min¡1), peak oxygen uptake per kg; VO2peak (ml kgFFM
¡1 min¡1), peak oxygen uptake per kg fat-free mass; VAT
(% predicted VO2peak) ventilatory anaerobic threshold as percentage of predicted VO2peak; sed, sedentary normative values; recr, recreational norma-
tive values (people who exercise no more than 1–2 h a week); 6MWD, 6-min walk distance; PT, peak torque; PF, physical functioning; SF, social
functioning; Rlp, Role limitations physical; Rle, Role limitations emotional; MH, mental health; VT, vitality; BP, bodily pain; GH, general health per-
ception; CH, changes in health
a n = 17, because the thickness of the subscapular skinfold could not be measured reliably in one patient
b n = 14, because of thickness of the skin at the place of the cicatrice in four patients
Physical Wtness RAND-36 domain
PF SF Rlp Rle MH VT BP GH CH
Cardiorespiratory Wtness
VO2peak (ml kg¡1 min¡1) 0.55 –– – –––––
% of sedentary norm – 0.42 – – – 0.50 –––
% of recreational norm 0.48 – ––– 0.51 –––
VO2peak (ml kgFFM
¡1 min¡1)a 0.57 0.51 0 . 4 1 – –––––
% of sedentary norma – 0.56 ––– 0.59 –0 . 4 8 –
% of recreational norma 0.46 0.58 ––– 0.58 –––
VAT (% predicted VO2peak s e d ) ––– – –––––
VAT (% predicted VO2peak r e c r ) ––– – –––––
6MWD (m) 0.67 0.57 ––0.53 – 0.54 ––
% of norm – 0.70 ––– 0.51 ––0 . 4 4
Neuromuscular Wtness
PT extension at 60°/s (Nm) 0.44 – – – .41 – – – –
% of norm – 0.68 ––– – 0.56 ––
PT extension at 180°/s (Nm) – – – – – – 0.44 – –
% of norm – 0.51 – 0.54 ––0.50 ––
Body composition
Body mass index (kg m¡2) ––– – –––––
Waist circumference (cm)b ––– 0.49 – 0 . 4 1 –––––
Body fat (%)a –– – ––––352 Eur J Appl Physiol (2007) 100:345–353
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found only few relationships between body composition
and HRQoL.
Our results on the relationships between physical Wtness
and HRQoL imply that rehabilitation programs aimed at
improving physical Wtness (particularly cardiorespiratory
Wtness) may consequently result in improved HRQoL, par-
ticularly in improved physical and social functioning, vital-
ity, and bodily pain. However, these implications have to
be conWrmed in future randomized trials on the eVects of
such rehabilitation programs in liver transplant recipients.
Conclusion
Cardiorespiratory Wtness in the liver transplant recipients
was distinctly impaired and the prevalence of obesity was
higher than in the general population; there were no indica-
tions that neuromuscular Wtness is impaired after LTx.
Based on the relationships we found between cardiorespira-
tory Wtness and severity of fatigue, a rehabilitation program
aimed at enhancing cardiorespiratory Wtness may help in
reducing complaints of fatigue after LTx. Such rehabilita-
tion programs may also result in improved HRQoL.
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